![Andrew Gardiner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Stapleton | M | 55 |
Libero Pharma Ltd.
![]() Libero Pharma Ltd. Pharmaceuticals: MajorHealth Technology Libero Pharma Ltd. is a British company that aims to improve addiction management by mitigating the issues associated with existing formulations of naltrexone. The company is based in Edinburgh, UK. Naltrexone is a prescription medicine used for addiction management in the USA, which works by blocking the effects of drugs known as opiates. However, its utility is limited by the current delivery methods, which include oral and intramuscular injection. Libero Pharma was founded by Andrew Gardiner, who has been the CEO since incorporation. | - |
McHoul David | M | - |
Syntropharma Ltd.
![]() Syntropharma Ltd. Pharmaceuticals: MajorHealth Technology Syntropharma Ltd. produces and distributes pharmaceutical products. It specializes in the development of the skin patches of proven medicines targeting diseases affecting the central nervous system. The company was founded by Andrew Gardiner and David McHoul on February 1, 2005 and is headquartered in Newtown St Boswells, the United Kingdom. | 18 years |
Kevin Moore | M | - |
Syntropharma Ltd.
![]() Syntropharma Ltd. Pharmaceuticals: MajorHealth Technology Syntropharma Ltd. produces and distributes pharmaceutical products. It specializes in the development of the skin patches of proven medicines targeting diseases affecting the central nervous system. The company was founded by Andrew Gardiner and David McHoul on February 1, 2005 and is headquartered in Newtown St Boswells, the United Kingdom. | - |
Iain Scott | M | - |
Syntropharma Ltd.
![]() Syntropharma Ltd. Pharmaceuticals: MajorHealth Technology Syntropharma Ltd. produces and distributes pharmaceutical products. It specializes in the development of the skin patches of proven medicines targeting diseases affecting the central nervous system. The company was founded by Andrew Gardiner and David McHoul on February 1, 2005 and is headquartered in Newtown St Boswells, the United Kingdom. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrew Gardiner
- Personal Network